Make your money go further for just 25p per day

AIM IHT

AIM Innovators: Creo Medical initiates partnership strategy

Hospital beds and nurse image
  • Creo Medical provides update on its partnership plans
  • Belluscura shares drop on supply chain worries
  • ITM Power set to announce results this week

Creo Medical (CREO) is continuing to deliver on the goals set out in its 2016 IPO – just about. It’s true that the surgical endoscopy company might have been a little ambitious with its quest for commercialisation – initiating general sales roll-out by 2019 was always going to be tricky and the group’s first material revenue (£9.4m in the financial year to December 2020) came largely from acquisitions rather than the group’s own product roll-out.…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Belluscura

Impairments | Dividend reinstatement | Bonkers Bargain

16/08/2023 · Company Insights

News covered here include disappointing results from another company following a buy and build strategy, although…


AIM Innovators: Creo Medical initiates partnership strategy

24/01/2022 · Company Insights

Sign-up to our free email updates

SIGN UP